Subtypes of breast cancer: relation to risk factors and prognosis
- Prosjektnummer
- 46040000
- Ansvarlig person
- Lars Vatten
- Institusjon
- NTNU, ISM
- Prosjektkategori
- Flerårig prosjekt 2010
- Helsekategori
- Cancer
- Forskningsaktivitet
- 2. Aetiology, 4. Detection and Diagnosis
Invasive lobular breast cancer: the prognostic impact of histopathological grade, E-cadherin and molecular subtypes.
Histopathology 2015 Feb;66(3):409-19. Epub 2014 des 22
PMID: 25283075
Reproductive history and the risk of molecular breast cancer subtypes in a prospective study of Norwegian women.
Cancer Causes Control 2014 Jul;25(7):881-9. Epub 2014 mai 1
PMID: 24789514
Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women.
Int J Cancer 2014 Dec 1;135(11):2678-86. Epub 2014 apr 29
PMID: 24752603
TOP2A gene copy number change in breast cancer.
J Clin Pathol 2014 May;67(5):420-5. Epub 2014 jan 8
PMID: 24403186
Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients.
Breast Cancer Res Treat 2013 Aug;140(3):463-73. Epub 2013 jul 31
PMID: 23901018
Reproductive factors and the risk of breast cancer in old age: a Norwegian cohort study.
Breast Cancer Res Treat 2013 May;139(1):237-43. Epub 2013 apr 19
PMID: 23605085
The association of reproductive factors and breastfeeding with long term survival from breast cancer.
Breast Cancer Res Treat 2011 Nov;130(1):175-82. Epub 2011 mai 8
PMID: 21553291
Joint effects of nulliparity and other breast cancer risk factors.
Br J Cancer 2011 Aug;105(5):731-6. Epub 2011 aug 2
PMID: 21811252
Risk factors for breast cancer subtypes and breast cancer in old age
- Disputert:
- november 2014
- Hovedveileder:
- Bjørn Olav Åsvold
- Bjørn Olav Åsvold Hovedveileder
- Julie Horn Doktorgradsstipendiat
- Monica J Engstrøm Doktorgradsstipendiat
- Signe Opdahl Postdoktorstipendiat
- Anna Mary Bofin Prosjektleder
- Mirjam Delange Alsaker Doktorgradsstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Helse Midt-Norge RHF - Samarbeidsorganet og FFU